Epigenome-wide association study for Parkinson's disease

Area of Science:

• Epigenetics
• Neuroscience
• Genetics

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder often accompanied by anxiety.
• Understanding the epigenetic underpinnings of PD and its comorbidities is crucial for developing targeted therapies.

Purpose of the Study:

• To identify genes and pathways with significant DNA methylation changes in individuals with Parkinson's disease.
• To investigate epigenetic alterations associated with anxiety in Parkinson's disease patients.
• To validate top methylation sites in an independent cohort.

Main Methods:

• Epigenome-wide association study (EWAS) using the Infinium HumanMethylation 450K beadchip.
• Analysis of DNA methylation differences between Parkinson's disease cases and controls.
• Analysis of methylation differences between Parkinson's disease patients with and without anxiety.
• Replication of top differentially methylated loci using Sequenom EpiTYPER in an independent cohort.

Main Results:

• Twenty unique genes showed significant methylation differences between PD cases and controls (P(adjusted) < 0.05, Δβ ≥ 0.2).
• Seventeen genes exhibited significant methylation changes between PD with anxiety and PD without anxiety.
• FANCC (cg14115740) and TNKS2 (cg11963436) demonstrated significant and consistent differential methylation between PD cases and controls across both discovery and replication analyses.

Conclusions:

• DNA methylation patterns are altered in Parkinson's disease and its associated anxiety.
• FANCC and TNKS2 are promising candidate genes for further investigation as potential biomarkers for Parkinson's disease.
• Epigenetic modifications may play a role in the pathogenesis of Parkinson's disease and its comorbidities.